| Cannabidiol as a promising strategy to treat and prevent movement disorders? FF Peres, AC Lima, JEC Hallak, JA Crippa, RH Silva, VC Abílio Frontiers in pharmacology 9, 482, 2018 | 203 | 2018 |
| Cannabidiol exhibits anxiolytic but not antipsychotic property evaluated in the social interaction test V Almeida, R Levin, FF Peres, ST Niigaki, MB Calzavara, AW Zuardi, ... Progress in Neuro-Psychopharmacology and Biological Psychiatry 41, 30-35, 2013 | 115 | 2013 |
| Cannabidiol prevents motor and cognitive impairments induced by reserpine in rats FF Peres, R Levin, MA Suiama, MC Diana, DA Gouvêa, V Almeida, ... Frontiers in pharmacology 7, 343, 2016 | 80 | 2016 |
| Effects of cannabinoid drugs on the deficit of prepulse inhibition of startle in an animal model of schizophrenia: the SHR strain R Levin, FF Peres, V Almeida, MB Calzavara, AW Zuardi, JEC Hallak, ... Frontiers in pharmacology 5, 10, 2014 | 77 | 2014 |
| Cannabidiol administered during peri-adolescence prevents behavioral abnormalities in an animal model of schizophrenia FF Peres, MC Diana, R Levin, MA Suiama, V Almeida, AM Vendramini, ... Frontiers in Pharmacology 9, 901, 2018 | 59 | 2018 |
| Effects of cannabinoid and vanilloid drugs on positive and negative-like symptoms on an animal model of schizophrenia: the SHR strain V Almeida, FF Peres, R Levin, MA Suiama, MB Calzavara, AW Zuardi, ... Schizophrenia research 153 (1-3), 150-159, 2014 | 58 | 2014 |
| Antipsychotic profile of cannabidiol and rimonabant in an animal model of emotional context processing in schizophrenia R Levin, V Almeida, F Fiel Peres, M Bendlin Calzavara, N Derci da Silva, ... Current pharmaceutical design 18 (32), 4960-4965, 2012 | 55 | 2012 |
| Peripubertal treatment with cannabidiol prevents the emergence of psychosis in an animal model of schizophrenia FF Peres, MC Diana, MA Suiama, V Justi, V Almeida, RA Bressan, ... Schizophrenia research 172 (1-3), 220-221, 2016 | 33 | 2016 |
| Is cannabidiol during neurodevelopment a promising therapy for schizophrenia and autism spectrum disorders? CM Loss, L Teodoro, GD Rodrigues, LR Moreira, FF Peres, AW Zuardi, ... Frontiers in pharmacology 11, 635763, 2021 | 31 | 2021 |
| Thimet oligopeptidase (EC 3.4. 24.15) key functions suggested by knockout mice phenotype characterization NB Dos Santos, RD Franco, R Camarini, CD Munhoz, RAS Eichler, ... Biomolecules 9 (8), 382, 2019 | 27 | 2019 |
| Cannabidiol, among other cannabinoid drugs, modulates prepulse inhibition of startle in the SHR animal model: implications for schizophrenia pharmacotherapy FF Peres, R Levin, V Almeida, AW Zuardi, JE Hallak, JA Crippa, VC Abilio Frontiers in Pharmacology 7, 303, 2016 | 27 | 2016 |
| Young spontaneously hypertensive rats (SHRs) display prodromal schizophrenia-like behavioral abnormalities ST Niigaki, FF Peres, L Ferreira, T Libanio, DA Gouvea, R Levin, ... Progress in Neuro-Psychopharmacology and Biological Psychiatry 90, 169-176, 2019 | 24 | 2019 |
| Role of the endocannabinoid and endovanilloid systems in an animal model of schizophrenia-related emotional processing/cognitive deficit V Almeida, R Levin, FF Peres, MA Suiama, AM Vendramini, CM Santos, ... Neuropharmacology 155, 44-53, 2019 | 23 | 2019 |
| A schizophrenia-like behavioral trait in the SHR model: Applying confirmatory factor analysis as a new statistical tool FF Peres, RÁ Eufrásio, DA Gouvêa, MC Diana, CM Santos, W Swardfager, ... Progress in Neuro-Psychopharmacology and Biological Psychiatry 85, 16-22, 2018 | 21 | 2018 |
| Sodium nitroprusside is effective in preventing and/or reversing the development of schizophrenia‐related behaviors in an animal model: the SHR strain MC Diana, FF Peres, V Justi, RA Bressan, ALT Lacerda, JA Crippa, ... CNS neuroscience & therapeutics 24 (7), 624-632, 2018 | 19 | 2018 |
| COVID‐19 and Obesity: An Epidemiologic Analysis of the Brazilian Data DA Gonçalves, V Ribeiro, A Gualberto, F Peres, M Luconi, J Gameiro International journal of endocrinology 2021 (1), 6667135, 2021 | 16 | 2021 |
| Peripubertal exposure to environmental enrichment prevents schizophrenia-like behaviors in the SHR strain animal model CM Santos, FF Peres, MC Diana, V Justi, MA Suiama, MG Santana, ... Schizophrenia Research 176 (2-3), 552-559, 2016 | 12 | 2016 |
| Cannabidiol administered during peri-adolescence prevents behavioral abnormalities in an animal model of schizophrenia. Front Pharmacol 2018; 9: 901 FF Peres, MC Diana, R Levin, MA Suiama, V Almeida, AM Vendramini | 7 | 2018 |
| Harmine impairs memory performance of treated rats and nontreated cagemates. TC Libânio, RA Eufrásio, SS Niigaki, FF Peres, RH Silva, AW Zuardi, ... Experimental and Clinical Psychopharmacology 30 (6), 751, 2022 | 4 | 2022 |
| Cannabidiol: An overview of its antipsychotic properties FF Peres, V Almeida, VC Abilio Handbook of cannabis and related pathologies, 787-794, 2017 | 3 | 2017 |
